Yayın:
Efficacy of bortezomib in combination chemotherapy on secondary plasma cell leukemia

Basit Görünüm
dc.contributor.authorBeksaç, Meral
dc.contributor.buuauthorAli, Rıdvan
dc.contributor.buuauthorÖzkalemkaş, Fahir
dc.contributor.buuauthorÖzkocaman, Vildan
dc.contributor.buuauthorÖzkan, Atilla
dc.contributor.buuauthorÖzçelik, Tülay
dc.contributor.buuauthorTunalı, Ahmet
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentİç Hastalıkları Ana Bilim Dalı
dc.contributor.researcheridAAH-1854-2021
dc.contributor.scopusid7201813027
dc.contributor.scopusid6601912387
dc.contributor.scopusid6603145040
dc.contributor.scopusid9250698600
dc.contributor.scopusid7005424333
dc.contributor.scopusid6602797853
dc.date.accessioned2024-02-29T11:03:25Z
dc.date.available2024-02-29T11:03:25Z
dc.date.issued2007-03-26
dc.description.abstractWe read with great interest the article by Finneganet al. [1] in a recent issue ofLeukemia & Lymphoma,describing the results of primary plasma cell leukemia(PPCL) treated with bortezomib. We would like todescribe and share our experience in a patient withsecondary plasma cell leukemia (SPCL), who wassuccessfully treated with a combination of one doseof bortezomib, doxorubicin and dexamethasone, andin whom complete remission was maintained withthe administration of a single dose of bortezomibevery 3 weeks.
dc.identifier.citationAli, R. vd. (2007). "Aspergillosis osteomyelitis and joint infection in a renal transplant recipient". Leukemia & Lymphoma, 48(7), 1426-1428.
dc.identifier.doi10.1080/10428190701370597
dc.identifier.endpage1428
dc.identifier.issn1042-8194
dc.identifier.issue7
dc.identifier.pubmed17613776
dc.identifier.scopus2-s2.0-34447545662
dc.identifier.startpage1426
dc.identifier.urihttps://www.tandfonline.com/doi/full/10.1080/10428190701370597
dc.identifier.urihttps://hdl.handle.net/11452/40085
dc.identifier.volume48
dc.identifier.wos000247779300028
dc.indexed.wosSCIE
dc.language.isoen
dc.publisherTaylor
dc.relation.collaborationYurt içi
dc.relation.journalLeukemia & Lymphoma
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectMultiple-myeloma cells
dc.subjectAgents
dc.subjectTherapy
dc.subjectOncology
dc.subjectHematology
dc.subject.emtreeAdult
dc.subject.emtreeAnorexia
dc.subject.emtreeBlood smear
dc.subject.emtreeBlood toxicity
dc.subject.emtreeBolus injection
dc.subject.emtreeBone marrow biopsy
dc.subject.emtreeCase report
dc.subject.emtreeCombination chemotherapy
dc.subject.emtreeContinuous infusion
dc.subject.emtreeDeep vein thrombosis
dc.subject.emtreeDrug efficacy
dc.subject.emtreeDrug treatment failure
dc.subject.emtreeFatigue
dc.subject.emtreeFlow cytometry
dc.subject.emtreeHuman
dc.subject.emtreeHuman tissue
dc.subject.emtreeInformed consent
dc.subject.emtreeLetter
dc.subject.emtreeLeukemia remission
dc.subject.emtreeLeukocyte count
dc.subject.emtreeMaintenance therapy
dc.subject.emtreeMale
dc.subject.emtreeMonotherapy
dc.subject.emtreeMultiple cycle treatment
dc.subject.emtreeMultiple myeloma
dc.subject.emtreePeripheral neuropathy
dc.subject.emtreePhysical examination
dc.subject.emtreePlasma cell
dc.subject.emtreePlasma cell leukemia
dc.subject.emtreePneumonia
dc.subject.emtreePriority journal
dc.subject.emtreePurpura
dc.subject.emtreeRecurrent cancer
dc.subject.emtreeSensory neuropathy
dc.subject.emtreeSingle drug dose
dc.subject.emtreeThrombocyte count
dc.subject.emtreeAlbumin
dc.subject.emtreeBeta 2 microglobulin
dc.subject.emtreeBlood clotting factor 5 leiden
dc.subject.emtreeBortezomib
dc.subject.emtreeCalcium
dc.subject.emtreeCd38 antigen
dc.subject.emtreeCd79a antigen
dc.subject.emtreeDexamethasone
dc.subject.emtreeDoxorubicin
dc.subject.emtreeHemoglobin
dc.subject.emtreeImmunoglobulin kappa chain
dc.subject.emtreeMelphalan
dc.subject.emtreePrednisone
dc.subject.emtreeThalidomide
dc.subject.emtreeVincristine
dc.subject.emtreeZoledronic acid
dc.subject.meshAntineoplastic combined chemotherapy protocols
dc.subject.meshBoronic acids
dc.subject.meshHumans
dc.subject.meshLeukemia, plasmacytic
dc.subject.meshMale
dc.subject.meshMiddle aged
dc.subject.meshMultiple myeloma
dc.subject.meshNeoplasms, second primary
dc.subject.meshPyrazines
dc.subject.meshTreatment outcome
dc.subject.wosOncology
dc.subject.wosHematology
dc.titleEfficacy of bortezomib in combination chemotherapy on secondary plasma cell leukemia
dc.typeArticle
dc.wos.quartileQ3 (Oncology)
dc.wos.quartileQ4 (Hematology)
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi/İç Hastalıkları Ana Bilim Dalı
local.indexed.atWOS
local.indexed.atScopus
local.indexed.atPubMed

Dosyalar

Orijinal seri

Şimdi gösteriliyor 1 - 1 / 1
Küçük Resim
Ad:
Ali_vd_2007
Boyut:
244.52 KB
Format:
Adobe Portable Document Format
İndir

Lisanslı seri

Şimdi gösteriliyor 1 - 1 / 1
Placeholder
Ad:
license.txt
Boyut:
1.71 KB
Format:
Item-specific license agreed upon to submission
Açıklama
İndir

Koleksiyonlar

İndeksli Yayınlar / Indexed Publications